Thomas E Shenk is a virologist, who has investigated gene functions and pathogenesis of adenovirus, a DNA tumor virus, and human cytomegalovirus, a member of the herpes family of viruses. His laboratory’s current areas of focus include the dissection of cytomegalovirus gene functions using genetic and proteomic approaches, viral persistence in epithelial cells, viral latency in hematopoietic cells and the impact of virus infection on cellular metabolism.
Dr Shenk received his BS in Biology from the University of Detroit and his PhD in Microbiology from Rutgers University studying with Victor Stollar. He trained as a Postdoctoral Fellow in Molecular Biology at Stanford University in the laboratory of Paul Berg. He is the recipient of the Eli Lilly Award from the American Society for Microbiology, an American Cancer Society Professorship and an Investigatorship from the Howard Hughes Medical Institute. He is a Fellow of the American Academy of Microbiology, the American Academy of Arts and Sciences and the American Association for the Advancement of Science; and he is a Member of the US National Academy of Sciences and the US Institute of Medicine.
Professor Shenk served as chair of Princeton’s Department of Molecular Biology for two terms. He has served as editor-in-chief of the Journal of Virology and as Chair of the Council for Research and Clinical Investigation of the American Cancer Society. He is a past president of the American Society for Virology and the American Society for Microbiology, and he served on the board of directors of Merck & Company for 11 years. He currently serves as a member of the boards of directors of the Fox Chase Cancer Center, the Hepatitis B Foundation and Forge Life Science, LLC.